On May 8, Singlera Genomics announced that its self-developed PDACatch test, a novel DNA methylation-based liquid biopsy test for detecting pancreatic cancer in high-risk populations, has been granted Breakthrough Medical Device designation by FDA.
Sansure Biotech announced that the company will invest CNY 90.93 million, accounting for 53.2% of the shares, and jointly establish Hunan Sansure Ansai Biotechnology.
The 3rd Key Raw Material & Parts Forum of China is scheduled to be held at Primus Hotel Nanchang International Expo City on 28 May in 2023.
The 5th IVD Distribution Enterprise Forum of China is scheduled to be held at Primus Hotel Nanchang International Expo City on 26 May in 2023.
Following the announcement by China’s foreign ministry that PCR test results will no longer be required for all inbound travelers from April 29 onwards, the highly anticipated CACLP 2023 has entered its final countdown with less than one month to go.
On April 27, Mindray released its annual report, showing that in 2022, it achieved revenue of 30.366 billion CNY, up 20.17% year-on-year, net profit attributable to shareholders of the listed company was 9.607 billion CNY, up 20.07% year-on-year; net cash flow from operating activities was 12.141 billion CNY, up 34.92% year-on-year, and basic earnings per share was 7.94 CNY.
OpGen announced on Tuesday that it has entered into a distribution partnership for its Unyvero A50 system and in vitro diagnostic tests with Fisher Healthcare, a division of Thermo Fisher Scientific.
Eastern Money Choice data shows that as of April 13, 28 listed companies in the medical device category have disclosed their 2022 annual reports, of which 18 companies have achieved year-on-year growth in net profit, accounting for 64.29%.
QuidelOrtho Corporation, a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, today announced preliminary revenue results for the first quarter ended April 2, 2023.
CACLP 2023 is not just a platform for those 1,400 exhibitors to showcase their latest products and technologies, but also an opportunity for industry professionals to learn and network. CACLP 2023 will feature a wide range of new products, academic and enterprise activities to attract more than 30,000 visitors from all over the world.
✔ All (90)
✔ Press release (10)
✔ Industry news (80)
Don’t miss important updates about the show and the in vitro diagnostic industry.
Sign-up for our newsletter today.
Copyright © 2026 GL events Ruihe (Shanghai) Exhibition Co., Ltd. All Rights Reserved. ( 沪ICP备12004745号-1 )
We deliver the latest IVD news straight to your inbox. Stay in touch with CACLP News.
sign-up for our newsletter today.
To ensure our newsletter hit your inbox, make sure to add @caclp.com to your safe senders list. And, as always, feel free to contact
us with any questions and thanks again for subscribing.